BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34500740)

  • 21. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
    Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
    PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
    Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
    Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
    Paul M; Kumar Panda M; Thatoi H
    J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
    Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and bioevaluation of novel unsaturated cyanoacetamide derivatives: In vitro and in silico exploration.
    Uddin KM; Meem MH; Akter M; Rahman S; Al-Gawati MA; Alarifi N; Albrithen H; Alodhayb A; Poirier RA; Bhuiyan MMH
    MethodsX; 2024 Jun; 12():102691. PubMed ID: 38660042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular docking and molecular dynamics study of flavonol synthase and flavonoid 3'-monooxygenase enzymes involved for the enrichment of kaempferol.
    Kumari G; Nigam VK; Pandey DM
    J Biomol Struct Dyn; 2023 Apr; 41(6):2478-2491. PubMed ID: 35105279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural analysis of binding functionality of folic acid-PEG dendrimers against folate receptor.
    Sampogna-Mireles D; Araya-Durán ID; Márquez-Miranda V; Valencia-Gallegos JA; González-Nilo FD
    J Mol Graph Model; 2017 Mar; 72():201-208. PubMed ID: 28110184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
    Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
    J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of paracetamol for reproductive disruption: molecular interaction, dynamics, and MM-PBSA based
    Abdi SAH; Ali A; Fatma Sayed S; Ali A; Shabee Hulhasan Abadi S; Tahir A; Afjal MA; Rashid H; Aly OM; Nagarajan S
    Toxicol Mech Methods; 2023 Jun; 33(5):349-363. PubMed ID: 36253940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the EGFR in cancer cells by fusion protein consisting of arazyme and third loop of TGF-alpha: an in silico study.
    Ghadaksaz A; Imani Fooladi AA; Mahmoodzadeh Hosseini H; Nejad Satari T; Amin M
    J Biomol Struct Dyn; 2022; 40(22):11744-11757. PubMed ID: 34379041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
    Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
    Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
    Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interacted mechanism of functional groups in ligand targeted with folate receptor via docking, molecular dynamic and MM/PBSA.
    Jiang Y; Wang C; Zhang M; Fei X; Gu Y
    J Mol Graph Model; 2019 Mar; 87():121-128. PubMed ID: 30537642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate Conjugated Polyethylene Glycol Probe for Tumor-Targeted Drug Delivery of 5-Fluorouracil.
    Sarwar S; Abdul Qadir M; Alharthy RD; Ahmed M; Ahmad S; Vanmeert M; Mirza MU; Hameed A
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier.
    Golani LK; Islam F; O'Connor C; Dekhne AS; Hou Z; Matherly LH; Gangjee A
    Bioorg Med Chem; 2020 Jun; 28(12):115544. PubMed ID: 32503687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
    Kumar R; Jade D; Gupta D
    J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Sinha P; Yadav AK
    J Biomol Struct Dyn; 2024 Jul; 42(10):5001-5014. PubMed ID: 37517053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.